{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:15:26Z","timestamp":1788455726082,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11726-9","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:17:29Z","timestamp":1788452249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Free energy perturbation and machine learning-assisted identification of novel molecules for the Mycobacterium tuberculosis KasA protein: a fragment-based drug design approach"],"prefix":"10.1007","author":[{"given":"Md Ataul","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ajmal","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Chikhale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Lutful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Abul","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"11726_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCTUBE.2025.100510","volume":"38","author":"TK Suvvari","year":"2025","unstructured":"Suvvari TK (2025) The persistent threat of tuberculosis \u2212 why ending TB remains elusive? J Clin Tuberc Other Mycobact Dis 38:100510. https:\/\/doi.org\/10.1016\/J.JCTUBE.2025.100510","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"11726_CR2","unstructured":"Global Tuberculosis Report 2025. https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025. Accessed 16 Apr 2026"},{"key":"11726_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/CSHPERSPECT.A017863","volume":"5","author":"KJ Seung","year":"2015","unstructured":"Seung KJ, Keshavjee S, Rich ML (2015) Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb Perspect Med 5:a017863. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A017863","journal-title":"Cold Spring Harb Perspect Med"},{"key":"11726_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1055\/S-0040-1714201","volume":"57","author":"R Prasad","year":"2021","unstructured":"Prasad R, Saxena H, Gupta N et al (2021) Treatment of drug-resistant tuberculosis: current status. Ann Natl Acad Med Sci 57:68\u201373. https:\/\/doi.org\/10.1055\/S-0040-1714201","journal-title":"Ann Natl Acad Med Sci"},{"key":"11726_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/JOIM.12264;JOURNAL:JOURNAL:09546820B;WGROUP:STRING:PUBLICATION","volume":"277","author":"SK Parida","year":"2015","unstructured":"Parida SK, Axelsson-Robertson R, Rao MV et al (2015) Totally drug-resistant tuberculosis and adjunct therapies. J Intern Med 277:388\u2013405. https:\/\/doi.org\/10.1111\/JOIM.12264;JOURNAL:JOURNAL:09546820B;WGROUP:STRING:PUBLICATION","journal-title":"J Intern Med"},{"key":"11726_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/NATURE.2012.9797;SUBJMETA","author":"K Rowland","year":"2012","unstructured":"Rowland K (2012) Totally drug-resistant TB emerges in India. Nature. https:\/\/doi.org\/10.1038\/NATURE.2012.9797;SUBJMETA","journal-title":"Nature"},{"key":"11726_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS11101431","volume":"11","author":"R Arrigoni","year":"2022","unstructured":"Arrigoni R, Ballini A, Topi S et al (2022) Antibiotic resistance to Mycobacterium tuberculosis and potential use of natural and biological products as alternative anti-mycobacterial agents. Antibiotics (Basel) 11:1431. https:\/\/doi.org\/10.3390\/ANTIBIOTICS11101431","journal-title":"Antibiotics (Basel)"},{"key":"11726_CR8","doi-asserted-by":"publisher","unstructured":"Radhakrishnan SK, Sundaramurthy V (2026) The lipid language of tuberculosis: Mycobacterium tuberculosis surface molecules in host interaction and drug resistance. mBio e0395925. https:\/\/doi.org\/10.1128\/MBIO.03959-25;JOURNAL:JOURNAL:MBIO;CTYPE:STRING:JOURNAL","DOI":"10.1128\/MBIO.03959-25;JOURNAL:JOURNAL:MBIO;CTYPE:STRING:JOURNAL"},{"key":"11726_CR9","doi-asserted-by":"publisher","unstructured":"Daff\u00e9 M, Qu\u00e9mard A, Marrakchi H (2017) Mycolic acids: from chemistry to biology. In: biogenesis of fatty acids, lipids and membranes, pp 1\u201336. https:\/\/doi.org\/10.1007\/978-3-319-43676-0_18-1","DOI":"10.1007\/978-3-319-43676-0_18-1"},{"key":"11726_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2018.02064\/TEXT","volume":"9","author":"AK Yadav","year":"2018","unstructured":"Yadav AK, Espaillat A, Cava F (2018) Bacterial strategies to preserve cell wall integrity against environmental threats. Front Microbiol 9:378897. https:\/\/doi.org\/10.3389\/FMICB.2018.02064\/TEXT","journal-title":"Front Microbiol"},{"key":"11726_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/J.GENDIS.2026.102034","author":"S Zhang","year":"2026","unstructured":"Zhang S, Liu R, Liu Q et al (2026) Mitochondrial fatty acid synthesis: the physiopathological role in cellular processes and human diseases. Genes Dis. https:\/\/doi.org\/10.1016\/J.GENDIS.2026.102034","journal-title":"Genes Dis"},{"key":"11726_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1128\/MMBR.68.3.501-517.2004","volume":"68","author":"E Schweizer","year":"2004","unstructured":"Schweizer E, Hofmann J (2004) Microbial type I fatty acid synthases (FAS): major players in a network of cellular FAS systems. Microbiol Mol Biol Rev 68:501\u2013517. https:\/\/doi.org\/10.1128\/MMBR.68.3.501-517.2004","journal-title":"Microbiol Mol Biol Rev"},{"key":"11726_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/1574-6968.12597","volume":"360","author":"X Duan","year":"2014","unstructured":"Duan X, Xiang X, Xie J (2014) Crucial components of mycobacterium type II fatty acid biosynthesis (Fas-II) and their inhibitors. FEMS Microbiol Lett 360:87\u201399. https:\/\/doi.org\/10.1111\/1574-6968.12597","journal-title":"FEMS Microbiol Lett"},{"key":"11726_CR14","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1074\/jbc.M806537200","volume":"284","author":"R Veyron-Churlet","year":"2009","unstructured":"Veyron-Churlet R, Molle V, Taylor RC et al (2009) The Mycobacterium tuberculosis \u03b2-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue. J Biol Chem 284:6414\u20136424. https:\/\/doi.org\/10.1074\/jbc.M806537200","journal-title":"J Biol Chem"},{"key":"11726_CR15","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.2174\/092986711795029636","volume":"18","author":"V Singh","year":"2011","unstructured":"Singh V, Mani I, Chaudhary DK, Somvanshi P (2011) The \u03b2-ketoacyl-ACP synthase from Mycobacterium tuberculosis as potential drug targets. Curr Med Chem 18:1318\u20131324. https:\/\/doi.org\/10.2174\/092986711795029636","journal-title":"Curr Med Chem"},{"key":"11726_CR16","doi-asserted-by":"publisher","first-page":"1008213","DOI":"10.3389\/FCIMB.2022.1008213\/TEXT","volume":"12","author":"RS Rudraraju","year":"2022","unstructured":"Rudraraju RS, Daher SS, Gallardo-Macias R et al (2022) Mycobacterium tuberculosis KasA as a drug target: structure-based inhibitor design. Front Cell Infect Microbiol 12:1008213. https:\/\/doi.org\/10.3389\/FCIMB.2022.1008213\/TEXT","journal-title":"Front Cell Infect Microbiol"},{"key":"11726_CR17","doi-asserted-by":"publisher","first-page":"34190","DOI":"10.1074\/jbc.M113.511436","volume":"288","author":"J Schiebel","year":"2013","unstructured":"Schiebel J, Kapilashrami K, Fekete A et al (2013) Structural basis for the recognition of mycolic acid precursors by KasA, a condensing enzyme and drug target from Mycobacterium tuberculosis. J Biol Chem 288:34190\u201334204. https:\/\/doi.org\/10.1074\/jbc.M113.511436","journal-title":"J Biol Chem"},{"key":"11726_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1054\/TUBE.2002.0333","volume":"82","author":"RA Slayden","year":"2002","unstructured":"Slayden RA, Barry CE (2002) The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) 82:149\u2013160. https:\/\/doi.org\/10.1054\/TUBE.2002.0333","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"11726_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22884-8","volume":"8","author":"PV Parvati Sai Arun","year":"2018","unstructured":"Parvati Sai Arun PV, Miryala SK, Rana A et al (2018) System-wide coordinates of higher order functions in host-pathogen environment upon Mycobacterium tuberculosis infection. Sci Rep 8(1):5079-. https:\/\/doi.org\/10.1038\/s41598-018-22884-8","journal-title":"Sci Rep"},{"key":"11726_CR20","doi-asserted-by":"publisher","first-page":"e70239","DOI":"10.1002\/DDR.70239;REQUESTEDJOURNAL:JOURNAL:10982299;WGROUP:STRING:PUBLICATION","volume":"87","author":"A Sharma","year":"2026","unstructured":"Sharma A, Singh G, Shrivastava R (2026) Halting tuberculosis in its tracks: advances and strategies for discovering therapeutic targets in Mycobacterium tuberculosis. Drug Dev Res 87:e70239. https:\/\/doi.org\/10.1002\/DDR.70239;REQUESTEDJOURNAL:JOURNAL:10982299;WGROUP:STRING:PUBLICATION","journal-title":"Drug Dev Res"},{"key":"11726_CR21","doi-asserted-by":"publisher","first-page":"7596","DOI":"10.1128\/JB.187.22.7596-7606.2005","volume":"187","author":"A Bhatt","year":"2005","unstructured":"Bhatt A, Kremer L, Dai AZ et al (2005) Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis. J Bacteriol 187:7596\u20137606. https:\/\/doi.org\/10.1128\/JB.187.22.7596-7606.2005","journal-title":"J Bacteriol"},{"key":"11726_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0969-2126(01)00583-4","volume":"9","author":"JG Olsen","year":"2001","unstructured":"Olsen JG, Kadziola A, Von Wettstein-Knowles P et al (2001) Structures of \u03b2-ketoacyl-acyl carrier protein synthase I complexed with fatty acids elucidate its catalytic machinery. Structure 9:233\u2013243. https:\/\/doi.org\/10.1016\/S0969-2126(01)00583-4","journal-title":"Structure"},{"key":"11726_CR23","doi-asserted-by":"publisher","first-page":"16857","DOI":"10.1074\/JBC.M000569200","volume":"275","author":"L Kremer","year":"2000","unstructured":"Kremer L, Douglas JD, Baulard AR et al (2000) Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem 275:16857\u201316864. https:\/\/doi.org\/10.1074\/JBC.M000569200","journal-title":"J Biol Chem"},{"key":"11726_CR24","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1074\/JBC.M112.414516","volume":"288","author":"K Kapilashrami","year":"2013","unstructured":"Kapilashrami K, Bommineni GR, MacHutta CA et al (2013) Thiolactomycin-based \u03b2-ketoacyl-AcpM synthase A (KasA) inhibitors: fragment-based inhibitor discovery using transient one-dimensional nuclear overhauser effect NMR spectroscopy. J Biol Chem 288:6045\u20136052. https:\/\/doi.org\/10.1074\/JBC.M112.414516","journal-title":"J Biol Chem"},{"issue":"1","key":"11726_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12581","volume":"7","author":"KA Abrahams","year":"2016","unstructured":"Abrahams KA, Chung CW, Ghidelli-Disse S et al (2016) Identification of KasA as the cellular target of an anti-tubercular scaffold. Nat Commun 7(1):12581-. https:\/\/doi.org\/10.1038\/ncomms12581","journal-title":"Nat Commun"},{"key":"11726_CR26","doi-asserted-by":"publisher","first-page":"1637254","DOI":"10.3389\/FMICB.2025.1637254\/FULL","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu R, Sun M et al (2025) Progress of anti-tuberculosis drug targets and novel therapeutic strategies. Front Microbiol 16:1637254. https:\/\/doi.org\/10.3389\/FMICB.2025.1637254\/FULL","journal-title":"Front Microbiol"},{"key":"11726_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/PH15111415","volume":"15","author":"MK Mallakuntla","year":"2022","unstructured":"Mallakuntla MK, Togre NS, Santos DB, Tiwari S (2022) Implications of fragment-based drug discovery in tuberculosis and HIV. Pharmaceuticals (Basel) 15:1415. https:\/\/doi.org\/10.3390\/PH15111415","journal-title":"Pharmaceuticals (Basel)"},{"key":"11726_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJMECH.2023.115569","volume":"258","author":"B Villemagne","year":"2023","unstructured":"Villemagne B, Faion L, Tangara S, Willand N (2023) Recent advances in fragment-based strategies against tuberculosis. Eur J Med Chem 258:115569. https:\/\/doi.org\/10.1016\/J.EJMECH.2023.115569","journal-title":"Eur J Med Chem"},{"key":"11726_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1021\/ACS.JMEDCHEM.1C01803","volume":"65","author":"IJP De Esch","year":"2021","unstructured":"De Esch IJP, Erlanson DA, Jahnke W et al (2021) Fragment-to-lead medicinal chemistry publications in 2020. J Med Chem 65:84\u201399. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.1C01803","journal-title":"J Med Chem"},{"key":"11726_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/NRD3926;SUBJMETA","volume":"12","author":"M Baker","year":"2013","unstructured":"Baker M (2013) Fragment-based lead discovery grows up. Nat Rev Drug Discov 12:5\u20137. https:\/\/doi.org\/10.1038\/NRD3926;SUBJMETA","journal-title":"Nat Rev Drug Discov"},{"key":"11726_CR31","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/J.NEURON.2018.08.011\/ASSET\/F4A0808D-6E29-4BAA-A1F0-68609B810994\/MAIN.ASSETS\/GR5.JPG","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth SA, Dror RO (2018) Molecular dynamics simulation for all. Neuron 99:1129\u20131143. https:\/\/doi.org\/10.1016\/J.NEURON.2018.08.011\/ASSET\/F4A0808D-6E29-4BAA-A1F0-68609B810994\/MAIN.ASSETS\/GR5.JPG","journal-title":"Neuron"},{"key":"11726_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/CI100275A\/SUPPL_FILE\/CI100275A_SI_001.PDF","volume":"51","author":"T Hou","year":"2011","unstructured":"Hou T, Wang J, Li Y, Wang W (2011) Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 51:69\u201382. https:\/\/doi.org\/10.1021\/CI100275A\/SUPPL_FILE\/CI100275A_SI_001.PDF","journal-title":"J Chem Inf Model"},{"key":"11726_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-76718-0_10","author":"D Antunes","year":"2024","unstructured":"Antunes D, Santos LH, Guimar\u00e3es ACR, Caffarena ER (2024) Free energy perturbation and free-energy calculations applied to drug. Design. https:\/\/doi.org\/10.1007\/978-3-031-76718-0_10","journal-title":"Design"},{"key":"11726_CR34","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.str.2009.04.012","volume":"17","author":"SR Luckner","year":"2009","unstructured":"Luckner SR, Machutta CA, Tonge PJ, Kisker C (2009) Crystal structures of Mycobacterium tuberculosis KasA show mode of action within cell wall biosynthesis and its inhibition by thiolactomycin. Structure 17:1004\u20131013. https:\/\/doi.org\/10.1016\/j.str.2009.04.012","journal-title":"Structure"},{"key":"11726_CR35","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/JCC.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Ruth H, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/JCC.21256","journal-title":"J Comput Chem"},{"key":"11726_CR36","doi-asserted-by":"publisher","first-page":"D1045","DOI":"10.1093\/NAR\/GKV1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson MK, Liu T, Baitaluk M et al (2016) BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res 44:D1045\u2013D1053. https:\/\/doi.org\/10.1093\/NAR\/GKV1072","journal-title":"Nucleic Acids Res"},{"key":"11726_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/BIOINFORMATICS\/BTAD012","author":"Y Diao","year":"2023","unstructured":"Diao Y, Hu F, Shen Z, Li H (2023) MacFrag: segmenting large-scale molecules to obtain diverse fragments with high qualities. Bioinformatics. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTAD012","journal-title":"Bioinformatics"},{"key":"11726_CR38","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/CMDC.200800178;WGROUP:STRING:PUBLICATION","volume":"3","author":"J Degen","year":"2008","unstructured":"Degen J, Wegscheid-Gerlach C, Zaliani A, Rarey M (2008) On the art of compiling and using \u201cdrug-like\u201d chemical fragment spaces. ChemMedChem 3:1503\u20131507. https:\/\/doi.org\/10.1002\/CMDC.200800178;WGROUP:STRING:PUBLICATION","journal-title":"ChemMedChem"},{"key":"11726_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/BIOINFORMATICS\/BTAE416","author":"K Swanson","year":"2024","unstructured":"Swanson K, Walther P, Leitz J et al (2024) ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries. Bioinformatics. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTAE416","journal-title":"Bioinformatics"},{"key":"11726_CR40","unstructured":"SilicoXplore (2025) SilicoScientia private limited. https:\/\/silicoxplore.ai"},{"issue":"8","key":"11726_CR41","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrd3926-c1","volume":"12","author":"H Jhoti","year":"2013","unstructured":"Jhoti H, Williams G, Rees DC, Murray CW (2013) The \u201crule of three\u201d for fragment-based drug discovery: where are we now? Nat Rev Drug Discov 12(8):644\u2013644. https:\/\/doi.org\/10.1038\/nrd3926-c1","journal-title":"Nat Rev Drug Discov"},{"key":"11726_CR42","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/ACS.JCIM.1C00203\/SUPPL_FILE\/CI1C00203_SI_002.ZIP","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model 61:3891\u20133898. https:\/\/doi.org\/10.1021\/ACS.JCIM.1C00203\/SUPPL_FILE\/CI1C00203_SI_002.ZIP","journal-title":"J Chem Inf Model"},{"key":"11726_CR43","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1021\/CI1001982","volume":"50","author":"S Mukherjee","year":"2010","unstructured":"Mukherjee S, Balius TE, Rizzo RC (2010) Docking validation resources: protein family and ligand flexibility experiments. J Chem Inf Model 50:1986\u20132000. https:\/\/doi.org\/10.1021\/CI1001982","journal-title":"J Chem Inf Model"},{"issue":"1","key":"11726_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/S13321-025-00946-0","volume":"17","author":"MP Ferla","year":"2025","unstructured":"Ferla MP, S\u00e1nchez-Garc\u00eda R, Skyner RE et al (2025) Fragmenstein: predicting protein\u2013ligand structures of compounds derived from known crystallographic fragment hits using a strict conserved-binding\u2013based methodology. J Cheminform 17(1):4. https:\/\/doi.org\/10.1186\/S13321-025-00946-0","journal-title":"J Cheminform"},{"key":"11726_CR45","doi-asserted-by":"publisher","unstructured":"Korb O, St\u00fctzle T, Exner TE (2006) PLANTS: Application of ant colony optimization to structure-based drug design. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 4150 LNCS:247\u2013258. https:\/\/doi.org\/10.1007\/11839088_22\/COVER","DOI":"10.1007\/11839088_22\/COVER"},{"key":"11726_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1021\/ACS.JCIM.7B00650\/SUPPL_FILE\/CI7B00650_SI_001.PDF","volume":"58","author":"J Jim\u00e9nez","year":"2018","unstructured":"Jim\u00e9nez J, \u0160kali\u010d M, Mart\u00ednez-Rosell G, De Fabritiis G (2018) KDEEP: protein-ligand absolute binding affinity prediction via 3D-convolutional neural networks. J Chem Inf Model 58:287\u2013296. https:\/\/doi.org\/10.1021\/ACS.JCIM.7B00650\/SUPPL_FILE\/CI7B00650_SI_001.PDF","journal-title":"J Chem Inf Model"},{"key":"11726_CR47","doi-asserted-by":"publisher","unstructured":"Landrum G, Tosco P, Kelley B, et al rdkit\/rdkit: 2020_03_1 (Q1 2020) Release. https:\/\/doi.org\/10.5281\/ZENODO.3732262","DOI":"10.5281\/ZENODO.3732262"},{"key":"11726_CR48","first-page":"2579","volume":"9","author":"L van der Maaten","year":"2008","unstructured":"van der Maaten L, Hinton G (2008) Visualizing data using t-SNE. J Mach Learn Res 9:2579\u20132605","journal-title":"J Mach Learn Res"},{"key":"11726_CR49","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/JCC.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B et al (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701\u20131718. https:\/\/doi.org\/10.1002\/JCC.20291","journal-title":"J Comput Chem"},{"key":"11726_CR50","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/JCC.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang J, Mackerell AD (2013) CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem 34:2135\u20132145. https:\/\/doi.org\/10.1002\/JCC.23354","journal-title":"J Comput Chem"},{"key":"11726_CR51","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/JCC.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32:2359\u20132368. https:\/\/doi.org\/10.1002\/JCC.21816","journal-title":"J Comput Chem"},{"key":"11726_CR52","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/JP003020W;CTYPE:STRING:JOURNAL","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L (2001) Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A 105:9954\u20139960. https:\/\/doi.org\/10.1021\/JP003020W;CTYPE:STRING:JOURNAL","journal-title":"J Phys Chem A"},{"key":"11726_CR53","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/ACS.JCTC.1C00645\/SUPPL_FILE\/CT1C00645_SI_001.PDF","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2021) Gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput 17:6281\u20136291. https:\/\/doi.org\/10.1021\/ACS.JCTC.1C00645\/SUPPL_FILE\/CT1C00645_SI_001.PDF","journal-title":"J Chem Theory Comput"},{"key":"11726_CR54","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/NAR\/GKV315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin S, Schreiber S, Haupt VJ et al (2015) PLIP: fully automated protein\u2013ligand interaction profiler. Nucleic Acids Res 43:W443\u2013W447. https:\/\/doi.org\/10.1093\/NAR\/GKV315","journal-title":"Nucleic Acids Res"},{"key":"11726_CR55","doi-asserted-by":"publisher","first-page":"22858","DOI":"10.1021\/ACSOMEGA.5C00151","volume":"10","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yang J (2025) Acceleration of the GROMACS free-energy perturbation calculations on GPUs. ACS Omega 10:22858\u201322873. https:\/\/doi.org\/10.1021\/ACSOMEGA.5C00151","journal-title":"ACS Omega"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11726-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11726-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11726-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:17:33Z","timestamp":1788452253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11726-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":55,"alternative-id":["11726"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11726-9","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors hereby declare that Md Ataul Islam is associated with SilicoScientia Private Limited. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All publicly available software integrated into SilicoXplore must be used in strict accordance with their respective original licensing terms and conditions, and the respective original sources must be properly cited when the tools are used via SilicoXplore. SilicoXplore does not alter the execution or results of these tools; it only makes them easier to use by providing a user-friendly interface. The proprietary tool must be cited in accordance with SilicoXplore\u2019s licensing terms and conditions.","order":2,"name":"Ethics","label":"Licensing policy","group":{"name":"EthicsHeading","label":"Declarations"}}]}}